PAR 3.76% $2.05 paradigm biopharmaceuticals limited..

I see debates about the use and costs of iPPS versus knee...

  1. 321 Posts.
    lightbulb Created with Sketch. 94
    I see debates about the use and costs of iPPS versus knee reconstructions/replacements. iPPs might not be able to help people who already have totally stuffed knees but this will not be the case over the long term.

    Correct me if I'm wrong about knees and OA but I understand it to be a progressive disease which shows some initial symptoms and gradually gets worse over time. I therefore expect that once iPPS is both approved and fully understood by the medical fraternity it might be used as the first line of treatment for everybody showing inital signs of OA.

    Doctors will prescribe it because it is effective. Insurers/agencies will be happy to pay for it if they believe it prevents further degeneration and the more significant costs of care and surgery that ultimately follow.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Mkt cap ! $394.3M
Open High Low Value Volume
$2.13 $2.14 $2.05 $1.259M 599.4K

Buyers (Bids)

No. Vol. Price($)
3 11112 $2.05

Sellers (Offers)

Price($) Vol. No.
$2.11 23130 3
View Market Depth
Last update - 16.10pm 17/09/2019 (20 minute delay) ?
-0.080 ( 1.49 %)
Open High Low Volume
$2.11 $2.13 $2.07 60991
Last updated 15.59pm 17/09/2019 (live) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.